Cargando…

A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019

The effects of cytokine inhibition in the different phases of the severe coronavirus disease 2019 (COVID-19) are currently at the center of intense debate, and preliminary results from observational studies and case reports offer conflicting results thus far. The identification of the correct timing...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Stefano, Ludovico, Bobbio-Pallavicini, Francesca, Manzo, Antonio, Montecucco, Carlomaurizio, Bugatti, Serena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572850/ https://www.ncbi.nlm.nih.gov/pubmed/33123149 http://dx.doi.org/10.3389/fimmu.2020.572635

Ejemplares similares

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline
por: Bugatti, Serena, et al.
Publicado: (2020)

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target
por: Bugatti, Serena, et al.
Publicado: (2021)

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
por: Bobbio-Pallavicini, Francesca, et al.
Publicado: (2004)

In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis
por: Sakellariou, Garifallia, et al.
Publicado: (2021)

The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis
por: De Stefano, Ludovico, et al.
Publicado: (2021)

Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis
por: Bugatti, Serena, et al.
Publicado: (2021)

Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective
por: Bugatti, Serena, et al.
Publicado: (2012)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018)

Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
por: Bugatti, Serena, et al.
Publicado: (2016)

Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis
por: D’Onofrio, Bernardo, et al.
Publicado: (2022)

B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
por: Bugatti, Serena, et al.
Publicado: (2014)

The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis
por: De Stefano, Ludovico, et al.
Publicado: (2023)

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
por: Atzeni, Fabiola, et al.
Publicado: (2008)

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs
por: Bugatti, Serena, et al.
Publicado: (2012)

The Draining Lymph Node in Rheumatoid Arthritis: Current Concepts and Research Perspectives
por: Benaglio, Francesca, et al.
Publicado: (2015)

No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission
por: Bozzalla Cassione, Emanuele, et al.
Publicado: (2022)

Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis
por: De Stefano, Ludovico, et al.
Publicado: (2023)

Rheumatoid arthritis treatment: the earlier the better to prevent joint damage
por: Monti, Sara, et al.
Publicado: (2015)

Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors
por: Manzo, Antonio, et al.
Publicado: (2016)

Insights Into the Concept of Rheumatoid Arthritis Flare
por: Bozzalla-Cassione, Emanuele, et al.
Publicado: (2022)

Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA database
por: Zanetti, Anna, et al.
Publicado: (2023)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy
por: Duru, Gizem, et al.
Publicado: (2020)

Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
por: Borghi, Maria Orietta, et al.
Publicado: (2022)

Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics
por: Abdallah, Florence, et al.
Publicado: (2021)

Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases
por: Sakellariou, Garifallia, et al.
Publicado: (2022)

Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study
por: Bogliolo, Laura, et al.
Publicado: (2022)

Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis
por: Ferraccioli, Gianfranco, et al.
Publicado: (2012)

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
por: Buckley, Leo F., et al.
Publicado: (2020)

Long-term efficacy and safety of biologics in rheumatoid arthritis
por: Montecucco, Carlomaurizio
Publicado: (2012)

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021)

Window of Opportunity
Publicado: (1996)

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
por: Szabo, Attila
Publicado: (2015)

The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
por: Bayati, Fatemeh, et al.
Publicado: (2021)

Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
por: Abid, Muhammad Abbas, et al.
Publicado: (2020)

Clinical Applications of Synovial Biopsy
por: Manzo, Antonio, et al.
Publicado: (2019)

CCL21 relationship with lymphoid neogenesis and lymphatic vascular system in chronically inflamed synovium
por: Manzo, A, et al.
Publicado: (2005)

Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease
por: Grieshaber-Bouyer, Ricardo, et al.
Publicado: (2019)

Therapeutic Potential of Regulatory T Cells in Preeclampsia—Opportunities and Challenges
por: Robertson, Sarah A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ooqq5bh5gidmkandqfsc7m577j